[pending] CLONIDINE TRANSDERMAL SYSTEM (CLONIDINE)
Pending LLM rewrite. Source: FDA_DRUG D-0473-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
CGMP Deviations: use of an unapproved raw material
The recalled product
- Product
- CLONIDINE TRANSDERMAL SYSTEM (CLONIDINE)
- Brand
- CLONIDINE TRANSDERMAL SYSTEM
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot: 100060002
- Exp.: 07/2026
- 100066802
- Exp.: 05/2027
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · CLONIDINE TRANSDERMAL SYSTEM
- ModerateClonidine Transdermal System patches recalled for impurities and degradation
FDA (Drugs) · 2021-11-24
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateGasco Isopropyl Alcohol 70% recalled nationwide for subpotency
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- ModerateGasco Isopropyl Alcohol 70% recalled for subpotent drug content
FDA (Drugs) · 2026-07-15